DANIELLE MROZIENSKI: Open Payments
NPI 1164829545 · CASSELBERRY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,187 in 43 payments from 23 companies in 2025. Trend: 2023 $163 · 2024 $287 · 2025 $1,187
Food & beverage: $1,187
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 4 | $160 |
| UCB, Inc. | 6 | $151 |
| Neurocrine BioSciences, Inc. | 1 | $120 |
| MDD US Operations, LLC | 1 | $104 |
| Biogen, Inc. | 3 | $79 |
| Merz Pharmaceuticals, LLC | 3 | $77 |
| Neurelis, Inc. | 3 | $66 |
| ACADIA Pharmaceuticals Inc | 2 | $45 |
| C2N Diagnostics, LLC | 2 | $40 |
| CATALYST PHARMACEUTICALS, INC. | 2 | $40 |
Products named: LEQEMBI, INGREZZA, Nayzilam, INBRIJA, Fintepla, VALTOCO, DAYBUE, PRECIVITYAD2.
Industry payments across FL — which companies pay providers there.
